Search research articles
Contact Us
Filters
Showing results (241-250 of 332) with videos related to
Page
of 34
Sort By:
Blood Cancer Journal
|
March 28, 2024
Bayesian interim analysis for prospective randomized studies: reanalysis of the acute myeloid leukemia HOVON 132 clinical trial
Niek G van der Maas, Jurjen Versluis, Kazem Nasserinejad, et al.
Blood
|
April 23, 2020
Thromboembolism prophylaxis in adult patients with acute lymphoblastic leukemia treated in the GRAALL-2005 study
Corentin Orvain, Marie Balsat, Emmanuelle Tavernier, et al.
Neurology
|
November 8, 2014
Sporadic late-onset nemaline myopathy with MGUS: long-term follow-up after melphalan and SCT
Nicol C Voermans, Olivier Benveniste, Monique C Minnema, et al.
Journal of Clinical Oncology : Official Journal of the American Society of Clinical Oncology
|
May 9, 2012
Comparative analysis of the value of allogeneic hematopoietic stem-cell transplantation in acute myeloid leukemia with monosomal karyotype versus other cytogenetic risk categories
Jan J Cornelissen, Dimitri Breems, Wim L J van Putten, et al.
Acta Haematologica
|
December 2, 2025
Hemophagocytic Syndromes in Adults: Real-World Data on Mortality from a Tertiary Reference Center
Tatiana Wojtovicova, Drahomir Aujesky, Joerg C Schefold, et al.
Journal of Clinical Oncology : Official Journal of the American Society of Clinical Oncology
|
December 30, 2015
Rituximab Maintenance for a Maximum of 5 Years After Single-Agent Rituximab Induction in Follicular Lymphoma: Results of the Randomized Controlled Phase III Trial SAKK 35/03
Christian Taverna, Giovanni Martinelli, Felicitas Hitz, et al.
Transfusion
|
June 27, 2014
Should the standard dimethyl sulfoxide concentration be reduced? Results of a European Group for Blood and Marrow Transplantation prospective noninterventional study on usage and side effects of dimethyl sulfoxide
Curly Morris, Liesbeth de Wreede, Marijke Scholten, et al.
Blood Advances
|
December 4, 2020
Prolonged rituximab maintenance in follicular lymphoma patients: long-term results of the SAKK 35/03 randomized trial
Alden A Moccia, Christian Taverna, Sämi Schär, et al.
Cancer Medicine
|
December 25, 2021
The added value of multi-state modelling in a randomized controlled trial: The HOVON 102 study re-analyzed
Katerina Bakunina, Hein Putter, Jurjen Versluis, et al.
The New England Journal of Medicine
|
March 18, 2011
Cytarabine dose for acute myeloid leukemia
Bob Löwenberg, Thomas Pabst, Edo Vellenga, et al.
Page
of 34
Search research articles
Search
Showing results (241-250 of 332) with videos related to
Sort By:
Page
of 34
Blood Cancer Journal
|
March 28, 2024
Bayesian interim analysis for prospective randomized studies: reanalysis of the acute myeloid leukemia HOVON 132 clinical trial
Niek G van der Maas, Jurjen Versluis, Kazem Nasserinejad, et al.
Blood
|
April 23, 2020
Thromboembolism prophylaxis in adult patients with acute lymphoblastic leukemia treated in the GRAALL-2005 study
Corentin Orvain, Marie Balsat, Emmanuelle Tavernier, et al.
Neurology
|
November 8, 2014
Sporadic late-onset nemaline myopathy with MGUS: long-term follow-up after melphalan and SCT
Nicol C Voermans, Olivier Benveniste, Monique C Minnema, et al.
Journal of Clinical Oncology : Official Journal of the American Society of Clinical Oncology
|
May 9, 2012
Comparative analysis of the value of allogeneic hematopoietic stem-cell transplantation in acute myeloid leukemia with monosomal karyotype versus other cytogenetic risk categories
Jan J Cornelissen, Dimitri Breems, Wim L J van Putten, et al.
Acta Haematologica
|
December 2, 2025
Hemophagocytic Syndromes in Adults: Real-World Data on Mortality from a Tertiary Reference Center
Tatiana Wojtovicova, Drahomir Aujesky, Joerg C Schefold, et al.
Journal of Clinical Oncology : Official Journal of the American Society of Clinical Oncology
|
December 30, 2015
Rituximab Maintenance for a Maximum of 5 Years After Single-Agent Rituximab Induction in Follicular Lymphoma: Results of the Randomized Controlled Phase III Trial SAKK 35/03
Christian Taverna, Giovanni Martinelli, Felicitas Hitz, et al.
Transfusion
|
June 27, 2014
Should the standard dimethyl sulfoxide concentration be reduced? Results of a European Group for Blood and Marrow Transplantation prospective noninterventional study on usage and side effects of dimethyl sulfoxide
Curly Morris, Liesbeth de Wreede, Marijke Scholten, et al.
Blood Advances
|
December 4, 2020
Prolonged rituximab maintenance in follicular lymphoma patients: long-term results of the SAKK 35/03 randomized trial
Alden A Moccia, Christian Taverna, Sämi Schär, et al.
Cancer Medicine
|
December 25, 2021
The added value of multi-state modelling in a randomized controlled trial: The HOVON 102 study re-analyzed
Katerina Bakunina, Hein Putter, Jurjen Versluis, et al.
The New England Journal of Medicine
|
March 18, 2011
Cytarabine dose for acute myeloid leukemia
Bob Löwenberg, Thomas Pabst, Edo Vellenga, et al.
Page
of 34